INS and hypertensive disorder: Furthermore, a clinical study comparing the metabolic effects of amlodipine and sacubitril/valsartan in obese patients with hypertension reported that sacubitril/valsartan treatment improved metabolic parameters and enhanced insulin sensitivity (38).